Skip to main content

ERRATUM article

Front. Immunol., 03 March 2023
Sec. Vaccines and Molecular Therapeutics
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1172427

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

This article is an erratum on:

  1. Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

    1. Read original article
Beln Aparicio,,Belén Aparicio1,2,3Marta Ruiz,,Marta Ruiz1,2,3Noelia Casares,Noelia Casares1,3Leyre Silva,,Leyre Silva1,2,3Josune Egea,,Josune Egea1,2,3Patricia Prez,Patricia Pérez4,5Guillermo AlbericioGuillermo Albericio4Mariano EstebanMariano Esteban4Juan García-Arriaza,Juan García-Arriaza4,5Juan J. Lasarte,*Juan J. Lasarte1,3*Pablo Sarobe,,*Pablo Sarobe1,2,3*
  • 1Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain
  • 2Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Pamplona, Spain
  • 3Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Pamplona, Spain
  • 4Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
  • 5Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain

An Erratum on
Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

by Aparicio B, Ruiz M, Casares N, Silva L, Egea J, Pérez P, Albericio G, Esteban M, García-Arriaza J, Lasarte JJ and Sarobe P (2023) Front. Immunol. 13:1044025. doi: 10.3389/fimmu.2022.1044025

Due to a production error, the Author Contributions statement was not updated to accurately reflect the contributions of the newly added authors PP, GA, JG-A and ME. The correct Author Contributions statement appears below.

Author contributions

“BA, JL and PS conceived and designed experiments. BA, MR, NC, LS, JE, PP, GA and JG-A performed the in silico, in vitro and in vivo studies. BA, PP, GA, JG-A, ME, JL and PS analyzed data and contributed to their interpretation. JL and PS supervised the project. ME, JG-A, JL and PS received funding. All authors reviewed the manuscript, approved the final version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.”

The publisher apologizes for this mistake. The original article has been updated.

Keywords: SARS-CoV-2, peptide vaccine, Omicron variant, cross-recognizing antibodies, conserved regions

Citation: Aparicio B, Ruiz M, Casares N, Silva L, Egea J, Pérez P, Albericio G, Esteban M, García-Arriaza J, Lasarte JJ and Sarobe P (2023) Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies. Front. Immunol. 14:1172427. doi: 10.3389/fimmu.2023.1172427

Received: 23 February 2023; Accepted: 23 February 2023;
Published: 03 March 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Aparicio, Ruiz, Casares, Silva, Egea, Pérez, Albericio, Esteban, García-Arriaza, Lasarte and Sarobe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Juan J. Lasarte, jjlasarte@unav.es; Pablo Sarobe, psarobe@unav.es

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.